Exelon Rate Base Is Growing 8% a Year. So, Why Is Its Free Cash Flow Still Negative?

Key Stats for Exelon Stock

• Current Price: $46.26
• Target Price (Mid): ~$69
• Street Target: ~$50
• Potential Total Return: ~49%
• Annualized IRR: ~9% / year
• Max Drawdown: 13.74% (May 15, 2026)

Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>

What Happened?

Exelon (EXC) is the kind of stock investors are supposed to be able to fall asleep on. It runs six regulated electric and gas utilities across the Mid-Atlantic and Midwest, collects predictable returns on a growing pile of infrastructure, and pays a dividend that has climbed every year through a rough regulatory stretch. Yet the market has kept it stuck in the mid-$40s, roughly 7% below the average analyst price target of around $50. The disagreement underneath that flat price is real. One camp sees a regulated compounder growing its earnings base at nearly 8% a year. The other looks at a company that has not produced positive free cash flow in years and just walked into a new fight with a governor over how much it is allowed to earn.

Both camps are looking at the same company. The gap between them is what makes the stock interesting right now, and management’s own moves this year have sharpened it rather than settled it. 

Maryland Just Turned an Affordability Law Into a Federal Complaint

On the Q1 call in May, CEO Calvin Butler noted that Maryland’s Utility RELIEF Act had passed the legislature and was awaiting Governor Wes Moore’s signature. That signature came days later, on May 12. The development worth watching landed on July 11, when Maryland’s Energy Administration, its Public Service Commission, and the Office of People’s Counsel jointly filed a complaint with federal regulators to end a PJM surcharge known as the RTO adder, a fee utilities collect for belonging to a regional grid operator. This is a filed complaint, not a ruling, and the adder itself is a modest, industry-wide charge rather than an Exelon-specific line item. But Exelon’s Maryland utilities collect it, so a win for the state chips at their revenue, and the direction of travel is what matters.

This is the affordability pressure Butler kept describing on the call, now pointed at utility revenue rather than debated in the abstract. He was blunt about the underlying problem. “You cannot have a conversation about affordability without addressing the underlying shortage of generation,” he told analysts. That framing is the company’s defense against a regulatory environment that increasingly wants lower bills without confronting why bills are high.

Exelon’s answer has been to reprice its own plan. It withdrew PECO’s Pennsylvania rate cases, pulled $350 million of operating costs out for 2027, and rebalanced its capital budget toward transmission, where the political tailwind is strongest. That is a company adapting in real time. It is also a company signaling that the returns it once assumed are now contested.

The Earnings Base Grows While the Cash Flow Goes the Other Way

A steady dividend hides a real tension in the numbers. Exelon reported first-quarter adjusted operating earnings of $0.91 per share, down a penny from $0.92 a year earlier, and reaffirmed full-year guidance of $2.81 to $2.91 per share. CFO Jeanne Jones said the company is holding rate base growth at 7.9% annually over the next four years. Rate base is the value of infrastructure a utility is allowed to earn a regulated return on, so growing it is the core engine of a utility’s earnings. On that measure, Exelon looks healthy.

The free cash flow line goes the other way. Exelon’s trailing free cash flow has been negative for years, and TIKR’s estimates show it staying negative through 2027 before barely crossing into positive territory in 2028. The reason is not distress. It is spending: the company plans to deploy $41.7 billion of capital over four years, including nearly $10 billion in 2026 alone, far more than its operations throw off. That gap gets funded with debt and a modest slug of equity, which Jones sized at $3.4 billion, or less than 2% of Exelon’s market cap.

For a regulated utility, that model can work because every approved dollar of spending becomes future rate base and future earnings. But it leaves the stock valued oddly. Exelon trades at a next-twelve-months multiple of enterprise value to EBITDA (a measure of operating profit before non-cash charges) of 10 times, cheaper than most large regulated peers. Constellation Energy trades near 12.9 times and IDACORP near 14.8 times. Part of that discount is the cash flow: investors pay less for earnings that do not convert to free cash the way a lower-capex business would. The rest reflects peers like Constellation carrying a generation-growth premium Exelon’s wires-only model does not.

See historical and forward estimates for Exelon stock (It’s free!) >>>

Transmission Is the Part of the Plan Regulators Are Not Fighting

If there is a reason to give Exelon the benefit of the doubt, it sits in one segment. Jones told investors the transmission rate base is set to grow 16% through 2029, more than double the pace of the overall base. Transmission is the piece least exposed to the affordability fights in Pennsylvania and Maryland, because it earns its returns through federal processes and is driven by reliability needs and new load rather than household bills. Butler pointed to roughly $1 billion of collateral already secured through FERC-approved agreements tied to data center demand, and the company has competitive bids in for two Illinois projects worth about $1.9 billion with Invenergy.

The risk is permission. Butler was candid that utilities were blocked from building generation for the 2028-2029 planning year, saying flatly that “had utilities been allowed to build generation for the ’28-’29 planning year, we would be in a materially stronger position today.” A company whose growth depends on regulators approving its spending is a company whose growth can be slowed when those regulators decide that affordability comes first.

See how Exelon performs against its peers in TIKR (It’s free!) >>>

TIKR Advanced Model Analysis

• Current Price: $46.26
• Target Price (Mid): ~$69
• Potential Total Return: ~49%
• Annualized IRR: ~9% / year

See analysts’ growth forecasts and price targets for Exelon stock (It’s free!) >>>

TIKR’s mid-case model values Exelon at around $69 by the end of 2030, roughly 49% total return, and about a 9% annualized rate from today’s $46.26. This is the mid-case, and it is the right one to anchor on because it assumes no heroic reversal of the trends already in place.

The target rests on two revenue drivers: rate base growth of about 8% a year across the utilities, and the faster 16% transmission expansion layered on top. The margin driver is net income margin rising toward 14% in the model’s forecast, up from around 11% today, as newer, higher-return investment mixes in. The primary risk is regulatory: every point of allowed return that Pennsylvania or Maryland claws back in the name of affordability comes straight out of this model.

The upside is a utility that keeps compounding its earnings base near 8% while the market slowly re-rates it toward peers as the capital cycle matures. The downside is that regulators cap returns and slow the spending, leaving investors with the low-single-digit total return the stock’s recent history has delivered.

Conclusion

The number to watch is free cash flow, and the date is July 30, when Exelon reports second-quarter results. Positive cash flow is not coming that soon, so the real test is narrower. Watch whether management holds the $41.7 billion capital plan, the 7.9% rate base growth, and the 16% transmission figure intact, or whether affordability pressure in Maryland and Pennsylvania forces another downward revision like the PECO withdrawal. Holding the plan tells the growth engine is intact, and the negative cash flow is a choice, not a warning. Trimming it again tells the regulators are winning, and the path to around $69 gets longer.

See what stocks billionaire investors are buying so you can follow the smart money with TIKR.

Should You Invest in Exelon?

The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.

Pull up Exelon, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.

You can build a free watchlist to track Exelon alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.

Analyze Exelon on TIKR Free →

Looking for New Opportunities?

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!